abstract |
Disclosed is a pharmaceutical composition having improved dissolution property, which contains olmesartan medoxomil and azelnidipine. Specifically disclosed is a pharmaceutical composition containing (A) olmesartan medoxomil, (B) azelnidipine and (C) a polyvinyl alcohol or a vinyl alcohol copolymer. |